{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:16:16Z","timestamp":1785838576688,"version":"3.56.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.joim.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T19:19:50Z","timestamp":1626981590000},"page":"375-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment"],"prefix":"10.1016","volume":"19","author":[{"given":"Andr\u00e9a D.","family":"Fuzimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joim.2021.07.003_b0005","series-title":"Artemisia annua pharmacology and biotechnology","author":"Aftab","year":"2014"},{"key":"10.1016\/j.joim.2021.07.003_b0010","doi-asserted-by":"crossref","first-page":"104901","DOI":"10.1016\/j.phrs.2020.104901","article-title":"Antimalarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","volume":"158","author":"Cheong","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joim.2021.07.003_b0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13020-020-00336-8","article-title":"Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?","volume":"15","author":"Uzun","year":"2020","journal-title":"Chin Med"},{"key":"10.1016\/j.joim.2021.07.003_b0020","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antivir Res"},{"issue":"18","key":"10.1016\/j.joim.2021.07.003_b0025","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","article-title":"Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","volume":"77","author":"Dyall","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.joim.2021.07.003_b0030","doi-asserted-by":"crossref","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; 71(15):732\u20139.","DOI":"10.1093\/cid\/ciaa237"},{"key":"10.1016\/j.joim.2021.07.003_b0035","first-page":"1","article-title":"Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19","author":"Sehailia","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0040","doi-asserted-by":"crossref","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","volume":"55","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents."},{"issue":"17","key":"10.1016\/j.joim.2021.07.003_b0045","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1503\/cmaj.200528","article-title":"Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection","volume":"192","author":"Juurlink","year":"2020","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1756-185X.13842","article-title":"A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19)","volume":"23","author":"Shah","year":"2020","journal-title":"Int J Rheuma Dis"},{"issue":"8","key":"10.1016\/j.joim.2021.07.003_b0055","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cmi.2020.05.016","article-title":"Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review","volume":"26","author":"Rodrigo","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.joim.2021.07.003_b0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.joim.2021.07.003_b0065","doi-asserted-by":"crossref","unstructured":"Kapepula PM, Kabengele JK, Kingombe M, Bambeke FV, Tulkens PM, Kishabongo AS, et al. Artemisia Spp. derivatives for COVID-19 treatment: anecdotal use, political hype, treatment potential, challenges, and road map to randomized clinical trials. Am J Trop Med Hyg 2020; 103(3): 960\u20134.","DOI":"10.4269\/ajtmh.20-0820"},{"key":"10.1016\/j.joim.2021.07.003_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/159819","article-title":"Essential oil of Artemisia annua L.: an extraordinary component with numerous antimicrobial properties","volume":"2014","author":"Bilia","year":"2014","journal-title":"Evid Based Complement Altern Med"},{"issue":"14","key":"10.1016\/j.joim.2021.07.003_b0075","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3390\/ijms21144986","article-title":"Artemisia annua, a traditional plant brought to light","volume":"21","author":"Septembre-Malaterre","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0080","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3390\/molecules15053135","article-title":"Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer","volume":"15","author":"Ferreira","year":"2010","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.joim.2021.07.003_b0085","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/molecules25112627","article-title":"Antiviral effects of plant-derived essential oils and their components: an updated review","volume":"25","author":"Ma","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.joim.2021.07.003_b0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jviromet.2011.03.005","article-title":"A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate","volume":"173","author":"Auerochs","year":"2011","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.joim.2021.07.003_b0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jep.2012.03.024","article-title":"Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua","volume":"141","author":"Lubbe","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10.1016\/j.joim.2021.07.003_b0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/432720","article-title":"Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects","volume":"41","author":"Li","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.joim.2021.07.003_b0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcme.2020.05.003","article-title":"The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds\u2014additional weapons in the fight against the COVID-19 pandemic?","volume":"10","author":"Fuzimoto","year":"2020","journal-title":"J Tradit Complement Med"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1389202916666150707160613","article-title":"RNA viruses: RNA roles in pathogenesis, coreplication and viral load","volume":"16","author":"Poltronieri","year":"2015","journal-title":"Curr Genomics"},{"issue":"7","key":"10.1016\/j.joim.2021.07.003_b0115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ptr.6077","article-title":"Combination of artemisinin-based natural compounds from Artemisia annua L. for the treatment of malaria: pharmacodynamic and pharmacokinetic studies","volume":"32","author":"Li","year":"2018","journal-title":"Phytother Res"},{"issue":"2","key":"10.1016\/j.joim.2021.07.003_b0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4269\/ajtmh.2004.70.128","article-title":"Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L (annual wormwood)","volume":"70","author":"Rath","year":"2004","journal-title":"Am Trop Med Hyg"},{"key":"10.1016\/j.joim.2021.07.003_b0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fct.2013.04.016","article-title":"Toxic essential oils. Part II: chemical, toxicological, pharmacological and microbiological profiles of Artemisia annua L. volatiles","volume":"58","author":"Radulovic","year":"2013","journal-title":"Food Chemm Toxicol"},{"key":"10.1016\/j.joim.2021.07.003_b0130","unstructured":"World Health Organization. Coronavirus disease (COVID-19), weekly epidemiological update 1. (2020-08-24) [2021-01-01]. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200824-weekly-epi-update.pdf?sfvrsn=806986d1_4."},{"issue":"7","key":"10.1016\/j.joim.2021.07.003_b0135","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan","volume":"180","author":"Wu","year":"2020","journal-title":"China. JAMA Intern Med"},{"key":"10.1016\/j.joim.2021.07.003_b0140","doi-asserted-by":"crossref","unstructured":"Barnes BJ, Adrover JM, Baxter-Stolzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 2020; 217(6): e20200652.","DOI":"10.1084\/jem.20200652"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jinf.2020.06.073","article-title":"Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?","volume":"81","author":"Gousseff","year":"2020","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.joim.2021.07.003_b0150","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/jmv.26114","article-title":"Retest positive for SARS-CoV-2 RNA of \u201crecovered\u201d patients with COVID-19: persistence, sampling issues, or re-infection?","volume":"92","author":"Kang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.joim.2021.07.003_b0155","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.bbi.2020.06.008","article-title":"A brewing storm: the neuropsychological sequelae of hyperinflammation due to COVID-19","volume":"88","author":"Cothran","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.joim.2021.07.003_b0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.joim.2021.07.003_b0165","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12192-020-01148-3","article-title":"Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19","volume":"25","author":"Marino Gammazza","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"7","key":"10.1016\/j.joim.2021.07.003_b0175","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/jcm9072038","article-title":"Does SARS-CoV-2 trigger stress-induced autoimmunity by molecular mimicry? A hypothesis","volume":"9","author":"Cappello","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0180","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism","volume":"25","author":"Lucchese","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"10.1016\/j.joim.2021.07.003_b0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","article-title":"Identification of natural compounds with antiviral activities against SARS-associated coronavirus","volume":"67","author":"Li","year":"2005","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.joim.2021.07.003_b0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00726-006-0403-1","article-title":"Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy","volume":"33","author":"Wang","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.joim.2021.07.003_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1763201","article-title":"An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study","volume":"13","author":"Das","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0200","first-page":"876","article-title":"In silico molecular docking studies of medicinal Arabic plant-based bioactive compounds as a promising drug candidate against COVID-19","volume":"5","author":"Alsaffar","year":"2020","journal-title":"Int J Innov Sci Res Technol"},{"key":"10.1016\/j.joim.2021.07.003_b0205","doi-asserted-by":"crossref","first-page":"100345","DOI":"10.1016\/j.imu.2020.100345","article-title":"Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: a computational study","volume":"19","author":"Peele","year":"2020","journal-title":"Inform Med Unlocked"},{"issue":"9","key":"10.1016\/j.joim.2021.07.003_b0210","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acsinfecdis.0c00522","article-title":"Anti-SARS-CoV-2 potential of artemisinins in vitro","volume":"6","author":"Cao","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.joim.2021.07.003_b0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijid.2020.08.032","article-title":"Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: in vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate","volume":"99","author":"Gendrot","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.joim.2021.07.003_b0220","doi-asserted-by":"crossref","first-page":"101873","DOI":"10.1016\/j.tmaid.2020.101873","article-title":"Antimalarial drugs inhibit the replication of SARS-CoV-2: an in vitro evaluation","volume":"37","author":"Gendrot","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"10","key":"10.1016\/j.joim.2021.07.003_b0225","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/ijms21103426","article-title":"Essential oils as antiviral agents, potential of essential oils to treat SARS-CoV-2 infection: an in silico investigation","volume":"21","author":"da Silva","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0230","doi-asserted-by":"crossref","first-page":"411","DOI":"10.6026\/97320630016411","article-title":"Molecular docking analysis of withaferin A from Withania somnifera with the glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease","volume":"16","author":"Sudeep","year":"2020","journal-title":"Bioinformation"},{"issue":"1","key":"10.1016\/j.joim.2021.07.003_b0235","doi-asserted-by":"crossref","first-page":"106216","DOI":"10.1016\/j.ijantimicag.2020.106216","article-title":"Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial","volume":"57","author":"Li","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.joim.2021.07.003_b0240","first-page":"1","article-title":"In silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)","author":"Sharma","year":"2020","journal-title":"J Biolol Struct Dyn"},{"key":"10.1016\/j.joim.2021.07.003_b0245","doi-asserted-by":"crossref","first-page":"107769","DOI":"10.1016\/j.jmgm.2020.107769","article-title":"Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus","volume":"102","author":"Prashantha","year":"2021","journal-title":"J Mol Graph Model"},{"issue":"4","key":"10.1016\/j.joim.2021.07.003_b0250","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s13337-020-00631-w","article-title":"Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters","volume":"31","author":"Roy Chattopadhyay","year":"2020","journal-title":"Virusdisease"},{"issue":"12","key":"10.1016\/j.joim.2021.07.003_b0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00894-020-04599-8","article-title":"Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates","volume":"26","author":"Alazmi","year":"2020","journal-title":"J Mol Model"},{"key":"10.1016\/j.joim.2021.07.003_b0260","first-page":"1","article-title":"Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study","author":"Khan","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"10.1016\/j.joim.2021.07.003_b0265","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ddr.21757","article-title":"Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach","volume":"82","author":"Marak","year":"2021","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.joim.2021.07.003_b0270","doi-asserted-by":"crossref","unstructured":"Gupta S, Singh V, Varadwaj PK, Chakravartty N, Katta AVSKM, Lekkala SP, et al. Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins. J Biomol Struct Dyn 2020; 1\u201320.","DOI":"10.1080\/07391102.2020.1837679"},{"issue":"4","key":"10.1016\/j.joim.2021.07.003_b0275","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01925-19","article-title":"Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle","volume":"94","author":"Cong","year":"2020","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.joim.2021.07.003_b0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0285","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pham Sin B"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0290","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","article-title":"COVID-19 spike-host cell receptor GRP78 binding site prediction","volume":"80","author":"Ibrahim","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.joim.2021.07.003_b0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.934492","article-title":"COVID-19 and the immune system","volume":"69","author":"Paces","year":"2020","journal-title":"Physiol Res"},{"issue":"6","key":"10.1016\/j.joim.2021.07.003_b0300","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u201cCytokine Storm\u201d in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.joim.2021.07.003_b0305","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.jinf.2020.06.061","article-title":"Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure","volume":"81","author":"Ueland","year":"2020","journal-title":"J Infect"},{"issue":"12","key":"10.1016\/j.joim.2021.07.003_b0310","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/acschemneuro.0c00294","article-title":"Vascular endothelial growth factor (VEGF) as a vital target for brain inflammation during the COVID-19 outbreak","volume":"11","author":"Yin","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.joim.2021.07.003_b0315","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.joim.2021.07.003_b0320","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","article-title":"Antimalarial agent artesunate inhibits TNF-\u03b1-induced production of proinflammatory cytokines via inhibition of NF-\u03baB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.joim.2021.07.003_b0325","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/biom10020254","article-title":"Dried leaf Artemisia annua improves bioavailability of artemisinin via cytochrome P450 inhibition and enhances artemisinin efficacy downstream","volume":"10","author":"Desrosiers","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.joim.2021.07.003_b0330","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/aps.2017.185","article-title":"Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages","volume":"39","author":"Yan","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.joim.2021.07.003_b0335","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10787-019-00678-2","article-title":"Unexpected mechanism of colitis amelioration by artesunate, a natural product from Artemisia annua L","volume":"28","author":"Sun","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"8","key":"10.1016\/j.joim.2021.07.003_b0340","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","article-title":"Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-\u03b1 and blocking the signaling pathway NF-\u03baB translocation","volume":"6","author":"Li","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.joim.2021.07.003_b0345","doi-asserted-by":"crossref","first-page":"e3321","DOI":"10.1371\/journal.pntd.0003321","article-title":"Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis","volume":"9","author":"Islamuddin","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0350","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11427-019-9550-4","article-title":"Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses","volume":"63","author":"Zhang","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.joim.2021.07.003_b0355","doi-asserted-by":"crossref","first-page":"100039","DOI":"10.1016\/j.medidd.2020.100039","article-title":"PAK1-blockers: potential therapeutics against COVID-19","volume":"6","author":"Maruta","year":"2020","journal-title":"Med Drug Discov"},{"issue":"7","key":"10.1016\/j.joim.2021.07.003_b0360","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14728222.2010.492779","article-title":"PAK1 as a therapeutic target","volume":"14","author":"Kichina","year":"2010","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"10.1016\/j.joim.2021.07.003_b0365","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ptr.5054","article-title":"Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity","volume":"28","author":"Maruta","year":"2014","journal-title":"Phytother Res"},{"issue":"11","key":"10.1016\/j.joim.2021.07.003_b0370","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ptr.6738","article-title":"Potential effects of curcumin in the treatment of COVID-19 infection","volume":"34","author":"Zahedipour","year":"2020","journal-title":"Phytother Res"},{"key":"10.1016\/j.joim.2021.07.003_b0375","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jep.2017.08.038","article-title":"Artemisinin permeability via Caco-2 cells increases after simulated digestion of Artemisia annua leaves","volume":"210","author":"Desrosiers","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2021.07.003_b0380","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jep.2016.06.041","article-title":"Effect of leaf digestion and artemisinin solubility for use in oral consumption of dried Artemisia annua leaves to treat malaria","volume":"190","author":"Desrosiers","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2021.07.003_b0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.phymed.2017.04.006","article-title":"Artemisia annua dried leaf tablets treated malaria resistant to ACT and i.v. artesunate: case reports","volume":"32","author":"Daddy","year":"2017","journal-title":"Phytomedicine"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:51:16Z","timestamp":1761864676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496421000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2095496421000637"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2021.07.003","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by ELSEVIER B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}